Pediatrics Doctors in Poulsbo, WA Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

John Joseph Corrales-diaz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 19245 7th Ave Ne, Poulsbo, WA 98370 Phone: 360-782-3500    Fax: 360-782-3540

Dr. Katie Ellgass, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 22180 Olympic College Way Nw, Poulsbo, WA 98370 Phone: 360-626-4031

Dr. Emily Cecile Macdonald, DO, FAAP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 22180 Olympic College Way Nw, Suite 203, Sound Pediatrics, Poulsbo, WA 98370 Phone: 360-626-4031    Fax: 360-626-4037

Bradley Troy Anderson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 19245 7th Ave Ne, Poulsbo, WA 98370 Phone: 360-782-3500    Fax: 360-782-3540

Dr. Violeta Mercedes Gomez, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2341 Ne Winlock Way, Poulsbo, WA 98370 Phone: 470-733-0321    Fax: 564-234-3327

Wendy Zeeben Hawley, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 20730 Bond Rd Ne, #208, Poulsbo, WA 98370 Phone: 360-779-7337    Fax: 360-779-7054

Bernie Jay Brown, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 20730 Bond Rd Ne, #208, Poulsbo, WA 98370 Phone: 360-779-7337    Fax: 360-779-7054

News Archive

Breakthrough in the understanding of the spread of cholera

Cholera is an acute intestinal infection caused by the bacterium Vibrio cholera and is spread by contaminated water and food. Scientists from the University of Haifa and Technion, the Israel Institute of Technology in Haifa, Israel, have reported in Environmental Microbiology, an important breakthrough in our understanding of the continental and intercontinental distribution of cholera.

FDA approves Boston Scientific's S-ICD system to treat sudden cardiac arrest

The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).

SNM commends FDA Advisory Committee recommendation for florbetapir approval

The Society of Nuclear Medicine (SNM) commends the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee on its recent recommendation for conditional approval of a new imaging agent, florbetapir.

Small businesses could benefit from insurance exchanges

Supporters of health reform legislation told a Senate subcommittee Tuesday that the insurance exchanges are critical for small businesses, which pay more than large companies to cover their employees and are cutting jobs and insurance coverage to control costs.

Pfizer board authorizes new $5 billion share repurchase program

Pfizer Inc. today announced that its board of directors authorized a new share repurchase program of up to $5 billion of its common stock. This is in addition to approximately $4 billion of authorization remaining under its current repurchase program and increases the company's total repurchase authorization to $9 billion.

Read more Medical News

› Verified 9 days ago